Coherus Oncology Inc (CHRS)

Cost of Revenue

$4.24M

Quarterly · Period ending: · USD

CHRS logo

CHRS Cost of Revenue

Latest reported$4.24M
CHRS Quarterly Cost of Revenue ($8.66M → $4.24M)
High-resolution chart · PNG

CHRS cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
4,242,000
4,695,000
4,941,000
4,687,000
4,411,000
3,699,000
33,858,000
20,741,000
29,555,000
1,439,000
84,567,000
32,703,000
24,848,000
16,874,000
14,202,000
35,234,000
11,277,000
9,370,000
12,104,000
21,280,000
16,696,000
7,511,000
11,673,000
9,000,000
10,139,000
6,855,000
7,805,000
6,447,000
601,000
2,225,000
26,663,000
27,741,000
26,519,000
25,455,000
30,930,000
42,626,000
33,200,000
53,775,000
59,010,000
64,573,000
65,544,000
65,313,000
51,051,000
68,218,000
56,944,000
36,467,000
26,867,000
18,496,000
18,925,000
13,936,000
9,222,000
4,934,000
8,467,000
8,656,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.